PharmTech Drug Digest 11.20
News|Articles|July 19, 2017

ChargePoint Adds US Office

ChargePoint Technology is expanding its US presence by opening a new office in San Francisco.

ChargePoint, a UK-headquartered company specializing in powder containment and aseptic transfer valves, will expand in North America by opening a new office in San Francisco, California. The new office will be the fourth globally, with other locations including Hong Kong and New Jersey.

“Growing our North American presence is a significant milestone for us and reflects our strategic vision to expand the company in key markets,” said Chris Eccles, CEO of ChargePoint, in a press release. “The use of split-valve technology is growing in popularity, and can offer an alternative to more cumbersome and costly containment techniques.”

Chris Rombach joins the team at the San Francisco office as president of ChargePoint Inc. He will be responsible for driving the growth of the entire ChargePoint offering across the United States, Canada, Mexico, and Puerto Rico, including the establishment of local sales operations and the creation of new roles in the US, as well as new reseller channels. The company plans to double its global workforce by 2020.

Source: ChargePoint


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.